OPVERSE Trademark

Trademark Overview

On Monday, October 20, 2025, a trademark application was filed for OPVERSE with the United States Patent and Trademark Office. The USPTO has given the OPVERSE trademark a serial number of 99452213. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, October 20, 2025. This trademark is owned by NATIONAL TAIWAN UNIVERSITY. The OPVERSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provision of biological research services; Provision of bacteriological research services; Conducting clinical trials for pharmaceutical drugs and reagents; Conducting clinical trial services; Research and analytical services relating to pharmaceutical drugs and reagents; Provision of medical research services; Research and development services in the field of allogeneic stem cell-based pharmaceuticals; Research and development services in the field of cell therapy and Contract Development and Manufacturing Organization (CDMO) solutions
opverse

General Information

Serial Number99452213
Word MarkOPVERSE
Filing DateMonday, October 20, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, October 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "OPVERSE".
Goods and ServicesProvision of biological research services; Provision of bacteriological research services; Conducting clinical trials for pharmaceutical drugs and reagents; Conducting clinical trial services; Research and analytical services relating to pharmaceutical drugs and reagents; Provision of medical research services; Research and development services in the field of allogeneic stem cell-based pharmaceuticals; Research and development services in the field of cell therapy and Contract Development and Manufacturing Organization (CDMO) solutions

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 20, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNATIONAL TAIWAN UNIVERSITY
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTaipei 10617
TW

Trademark Events

Event DateEvent Description
Monday, October 20, 2025NEW APPLICATION ENTERED
Monday, October 20, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

opverse services research provision development cell reagents pharmaceutical field drugs clinical